• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症中逼尿肌和尿道功能障碍:药物治疗的作用

Dysfunction of the detrusor and urethra in multiple sclerosis: the role of drug therapy.

作者信息

Awad S A, Wilson J W, Fenemore J, Kiruluta H G

出版信息

Can J Surg. 1982 May;25(3):259-62.

PMID:6123379
Abstract

Urinary tract disorders secondary to multiple sclerosis are common. In this series of 24 patients with multiple sclerosis, 5 had normal function of the detrusor, 3 had detrusor hypotonicity and 16 had detrusor hyperreflexia. The proximal urethra was evaluated using radiologic and electromyographic techniques. These studies showed that 5 patients had a normal urethra, 15 had some degree of somatic dyssynergia and 3 had sympathetic dyssynergia. Detrusor hyperreflexia with somatic dyssynergia was found in 11 patients and was the most common pattern. The therapeutic response to standard pharmacologic preparations was also evaluated. The regimen was based on the clinical and urodynamic findings for each patient. Dicyclomine hydrochloride was the drug of choice for detrusor hyperreflexia, bethanechol chloride for hypotonicity, dantrolene sodium for somatic dyssynergia and phenoxybenzamine hydrochloride for sympathetic dyssynergia. The authors found that most of their patients were amenable to drug therapy, the exception being those with advanced neurologic lesions.

摘要

继发于多发性硬化症的泌尿系统疾病很常见。在这组24例多发性硬化症患者中,5例逼尿肌功能正常,3例逼尿肌低张,16例逼尿肌反射亢进。使用放射学和肌电图技术评估近端尿道。这些研究表明,5例患者尿道正常,15例有一定程度的躯体协同失调,3例有交感神经协同失调。11例患者存在伴有躯体协同失调的逼尿肌反射亢进,这是最常见的模式。还评估了对标准药物制剂的治疗反应。治疗方案基于每位患者的临床和尿动力学检查结果。盐酸双环胺是治疗逼尿肌反射亢进的首选药物,氯化氨甲酰甲胆碱用于治疗低张,丹曲林钠用于治疗躯体协同失调,盐酸酚苄明用于治疗交感神经协同失调。作者发现,他们的大多数患者适合药物治疗,晚期神经病变患者除外。

相似文献

1
Dysfunction of the detrusor and urethra in multiple sclerosis: the role of drug therapy.多发性硬化症中逼尿肌和尿道功能障碍:药物治疗的作用
Can J Surg. 1982 May;25(3):259-62.
2
Pharmacologic treatment of disorders of bladder and urethra: a review.膀胱和尿道疾病的药物治疗:综述
Can J Surg. 1979 Nov;22(6):515-8.
3
The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.多发性硬化症患者尿动力学检查结果与头颅磁共振成像结果的相关性
J Urol. 1998 Mar;159(3):972-6.
4
Management of vesical dysfunction in multiple sclerosis.多发性硬化症膀胱功能障碍的管理
Urology. 1980 Oct;16(4):444-7. doi: 10.1016/0090-4295(80)90162-4.
5
Relationship of bladder dysfunction to lesion site in multiple sclerosis.多发性硬化症中膀胱功能障碍与病变部位的关系。
J Urol. 2003 Apr;169(4):1384-7. doi: 10.1097/01.ju.0000049644.27713.c8.
6
Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives.与多发性硬化症相关的膀胱尿道功能障碍:临床和尿动力学视角
J Urol. 1998 Jul;160(1):106-11.
7
[Bladder and sphincter disorders in multiple sclerosis. Clinical, urodynamic and neurophysiological study of 225 cases].[多发性硬化症中的膀胱和括约肌疾病。225例临床、尿动力学和神经生理学研究]
Rev Neurol (Paris). 1995 Dec;151(12):722-30.
8
Pharmacologic treatment of lower urinary tract dysfunction in the female patient.女性患者下尿路功能障碍的药物治疗
Urol Clin North Am. 1985 May;12(2):259-69.
9
Urinary dysfunction in multiple sclerosis.多发性硬化症中的排尿功能障碍。
J Clin Neurosci. 2009 Oct;16(10):1321-4. doi: 10.1016/j.jocn.2008.12.012. Epub 2009 Jun 27.
10
[Involvement of bladder neck and periurethral sphincter in dyssynergia in patients with spinal cord injury].[脊髓损伤患者排尿协同失调中膀胱颈和尿道周围括约肌的受累情况]
Arch Esp Urol. 2002 Apr;55(3):293-302.

引用本文的文献

1
Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico.视神经脊髓炎综合回顾及波多黎各视神经脊髓炎患者的临床特征
Surg Neurol Int. 2018 Dec 3;9:242. doi: 10.4103/sni.sni_224_18. eCollection 2018.
2
Raising awareness of the urological manifestations of multiple sclerosis.提高对多发性硬化症泌尿系统表现的认识。
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):65. doi: 10.5489/cuaj.4389.